Hirofumi Nakaoka
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 10
- Endometriosis Research and Treatment 9
- Obstetrics and Gynecology top 2%
- Immunology top 5%
- T-cell and B-cell Immunology 9
- Reproductive System and Pregnancy 7
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Genetics top 5%
- Genetic and phenotypic traits in livestock 5
-
- CRISPR and Genetic Engineering 8
-
- Animal Behavior and Welfare Studies 5
- Co-authors
- Ituro InoueKazuyoshi HosomichiKosuke YoshiharaTakayuki EnomotoTeiichi MotoyamaKazuaki SudaNejat MahdiehBahareh Rabbani
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hirofumi Nakaoka
86 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Reproductive Medicine 504
- Obstetrics and Gynecology 363
- Immunology 578
- Cancer Research 371
- Genetics 527
Countries citing papers authored by Hirofumi Nakaoka
This map shows the geographic impact of Hirofumi Nakaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Nakaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Nakaoka more than expected).
Fields of papers citing papers by Hirofumi Nakaoka
This network shows the impact of papers produced by Hirofumi Nakaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Nakaoka. The network helps show where Hirofumi Nakaoka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirofumi Nakaoka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 34 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 41 | |
| 9 | 2020 | 14 | |
| 10 | 2020 | 22 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 34 | |
| 13 | 2017 | 118 | |
| 14 | 2016 | 70 | |
| 15 | 2016 | 35 | |
| 16 | 2015 | 27 | |
| 17 | 2014 | 16 | |
| 18 | 2013 | 25 | |
| 19 | 2008 | 41 | |
| 20 | 2004 | 3 |
About Hirofumi Nakaoka
Hirofumi Nakaoka is a scholar working on Reproductive Medicine, Genetics and Cancer Research, having authored 89 papers that have together received 2.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), T-cell and B-cell Immunology (9 papers), Endometriosis Research and Treatment (9 papers), CRISPR and Genetic Engineering (8 papers), Cancer Genomics and Diagnostics (8 papers), Reproductive System and Pregnancy (7 papers), Genetic and phenotypic traits in livestock (5 papers) and Animal Behavior and Welfare Studies (5 papers). The work is most often cited by research in Reproductive Medicine (504 citations), Obstetrics and Gynecology (363 citations) and Immunology (578 citations). Hirofumi Nakaoka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Ituro Inoue, Ituro Inoue, Kazuyoshi Hosomichi, Kosuke Yoshihara, Takayuki Enomoto, Teiichi Motoyama, Kazuaki Suda, Nejat Mahdieh, Bahareh Rabbani and Tatsuya Ishiguro. Their work appears in journals such as PLoS ONE, Scientific Reports, Cancer Science, Stroke and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.